News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Asks for More Info on EnteroMedics (ETRMD)' Weight Loss Implant



9/25/2013 7:50:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Weight-loss devices maker EnteroMedics says it's still on track with its premarket approval application, expecting a decision early next year despite the FDA's request for more information. Minnesota medical device maker EnteroMedics (NSDQ:ETRM) appeared unfazed by the FDA's response to the company's premarket approval application, anticipating no slowdown in the regulatory process for its landmark Maestro weight-loss implant.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at BusinessWeek


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES